Cyclooxygenase-2 specificity and its clinical implications

Publisher Website

1 May 1999

journal article
review article
Published by Elsevier in The American Journal of Medicine

Vol. 106 (5) , 43S-50S
https://doi.org/10.1016/s0002-9343(99)00116-3

Abstract

No abstract available

Keywords

This publication has 5 references indexed in Scilit:

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
Arthritis & Rheumatism, 1998
Indexes of Severity for Osteoarthritis of the Hip and Knee:Validation–Value in Comparison with Other Assessment Tests
Scandinavian Journal of Rheumatology, 1987
An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa
Gastrointestinal Endoscopy, 1975
A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritis
Arthritis & Rheumatism, 1965
THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
JAMA, 1949